0002017198-24-000001.txt : 20240516 0002017198-24-000001.hdr.sgml : 20240516 20240516150639 ACCESSION NUMBER: 0002017198-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 EFFECTIVENESS DATE: 20240516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phythera Therapeutics Inc. CENTRAL INDEX KEY: 0002017198 ORGANIZATION NAME: IRS NUMBER: 320722911 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513537 FILM NUMBER: 24954994 BUSINESS ADDRESS: STREET 1: 103 ROCKVIEW CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (510) 205-7828 MAIL ADDRESS: STREET 1: 103 ROCKVIEW CITY: IRVINE STATE: CA ZIP: 92612 D 1 primary_doc.xml X0708 D LIVE 0002017198 Phythera Therapeutics Inc. 103 ROCKVIEW IRVINE CA CALIFORNIA 92612 (510) 205-7828 DELAWARE None None Corporation true 2021 Igor O. Nasonkin, Ph.D. 103 Rockview Irvine CA CALIFORNIA 92612 Executive Officer Director Promoter Charles S. Irving, Ph.D. 103 Rockview Irvine CA CALIFORNIA 92612 Executive Officer Director Promoter Hal Sternberg, Ph.D. 103 Rockview Irvine CA CALIFORNIA 92612 Executive Officer Director Promoter Judith Segall 103 Rockview Irvine CA CALIFORNIA 92612 Executive Officer Director Promoter Ngoc T. Tran 103 Rockview Irvine CA CALIFORNIA 92612 Executive Officer Promoter Zamira Nazirova Nasonkin 103 Rockview Irvine CA CALIFORNIA 92612 Promoter Biotechnology Decline to Disclose 06b false 2023-01-17 false true false 0 468 468 0 false 10 0 0 0 false Phythera Therapeutics Inc. Igor O. Nasonkin, Ph.D. Igor O. Nasonkin, Ph.D. Chief Executive Officer 2024-05-16